Prevalence of Pre-existing Antibodies to CRISPR-Associated Nuclease Cas9 in the USA Population

Vijaya L. Simhadri, Joseph R. McGill, Shane McMahon, Junxia Wang, Haiyan Jiang, Zuben E. Sauna

Molecular Therapy — Methods & Clinical Development · 2018 · 240 citations · 10 references

DOIFull text

Open access

Concepts

Abstract

(SpCas9) in human sera. Furthermore, using these assays to screen for pre-existing antibodies in 200 human serum samples, we found the prevalence of anti-SaCas9 and anti-SpCas9 antibodies to be 10% and 2.5%, respectively.

References

10